NextFin News — The Hong Kong Stock Exchange (HKEX) maintains a highly robust deal backlog, signaling resilient issuer confidence across regional capital markets.
Excluding confidential filings, there are currently 410 companies with a listing status of "Processing," alongside an additional six enterprises that have successfully cleared their listing hearings. Within this combined pool of 416 candidates, 57 issuers are utilizing specialized listing chapters designed specifically for biotechnology and specialist technology sectors.
Furthermore, the active pipeline includes over 100 companies that are already publicly traded on China's domestic A-share markets seeking dual-listing structures. This sizable volume underscores ongoing developer reliance on Hong Kong's financial infrastructure to secure global capital inflows.
Explore more exclusive insights at nextfin.ai.

